Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Patient Resources
COVID-19 Patient Resource Center
Clinical Trials
Search Clinical Trials
Patient Notification System
What is Clinical Research?
Volunteering for a Clinical Trial
Understanding Informed Consent
Useful Resources
FDA Approved Drugs
Professional Resources
Research Center Profiles
Clinical Trial Listings
Market Research
FDA Approved Drugs
Training Guides
Books
eLearning
Events
Newsletters
JobWatch
White Papers
Patient Education
SOPs
eCFR and Guidances
White Papers
Trial Listings
Advertise
COVID-19
iConnect
Sign In
Create Account
Sign Out
My Account
Home
» Regulatory Update
Looking to read the full article? Subscribe today!
Regulatory Update
October 1, 2019
FDA Releases Guidance on Drug Development for Fabry Disease
Upcoming Events
28
Sep
4th Annual WCG MCC Clinical Trial Risk & Performance Management Collaborative vSummit
18
Oct
MAGI's Clinical Research vConference — Fall 2021
Featured Products
Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant
Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs
Featured Stories
Despite Surge in Virtual Adaptations for Trials, Patient Perspective Should Be Kept at Forefront
Ask the Experts: FDA IND and nonIND Acceptance
With High Investigator Dropout Rates in Trials, Sites and Sponsors Must Offer More Support
Decentralization Leads Trials to Increasing Use of New Digital Tools, Report Shows
Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials
The information you need to adapt your monitoring plan to changing times.
Learn More Here
